CSPC Pharmaceutical Group Limited - Asset Resilience Ratio

Latest as of June 2025: 4.64%

CSPC Pharmaceutical Group Limited (CVG) has an Asset Resilience Ratio of 4.64% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€2.13 Billion

≈ $2.49 Billion USD Cash + Short-term Investments

Total Assets

€46.00 Billion

≈ $53.78 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how CSPC Pharmaceutical Group Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down CSPC Pharmaceutical Group Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€2.13 Billion	4.64%
Total Liquid Assets	€2.13 Billion	4.64%

Asset Resilience Insights

Limited Liquidity: CSPC Pharmaceutical Group Limited maintains only 4.64% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

CSPC Pharmaceutical Group Limited Industry Peers by Asset Resilience Ratio

Compare CSPC Pharmaceutical Group Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Roche Holding AG SW:ROG	Drug Manufacturers - General	15.37%
AstraZeneca PLC F:ZEGA	Drug Manufacturers - General	0.03%
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd SHE:300357	Drug Manufacturers - General	9.91%
Hangzhou Minsheng Healthcare Co Ltd SHE:301507	Drug Manufacturers - General	24.96%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%
Biogen Inc NASDAQ:BIIB	Drug Manufacturers - General	2.74%
Amarin Corporation PLC NASDAQ:AMRN	Drug Manufacturers - General	25.04%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	8.63%

Annual Asset Resilience Ratio for CSPC Pharmaceutical Group Limited (2016–2024)

The table below shows the annual Asset Resilience Ratio data for CSPC Pharmaceutical Group Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	3.32%	€1.47 Billion ≈ $1.72 Billion	€44.39 Billion ≈ $51.90 Billion	+0.99pp
2023-12-31	2.33%	€1.08 Billion ≈ $1.26 Billion	€46.28 Billion ≈ $54.11 Billion	-6.23pp
2022-12-31	8.56%	€3.57 Billion ≈ $4.18 Billion	€41.77 Billion ≈ $48.83 Billion	+4.40pp
2021-12-31	4.15%	€1.44 Billion ≈ $1.69 Billion	€34.74 Billion ≈ $40.62 Billion	-0.95pp
2020-12-31	5.11%	€1.54 Billion ≈ $1.79 Billion	€30.07 Billion ≈ $35.16 Billion	+5.10pp
2019-12-31	0.00%	€536.00K ≈ $626.64K	€26.32 Billion ≈ $30.77 Billion	+0.00pp
2018-12-31	0.00%	€441.76K ≈ $516.47K	€23.17 Billion ≈ $27.09 Billion	0.00pp
2017-12-31	0.00%	€611.66K ≈ $715.10K	€18.00 Billion ≈ $21.05 Billion	0.00pp
2016-12-31	0.00%	€466.51K ≈ $545.39K	€13.22 Billion ≈ $15.45 Billion	--

pp = percentage points

About CSPC Pharmaceutical Group Limited

F:CVG Germany Drug Manufacturers - General

Market Cap

$12.94 Billion

€11.07 Billion EUR

Market Cap Rank

#2216 Global

#459 in Germany

Share Price

€0.97

Change (1 day)

+2.87%

52-Week Range

€0.63 - €1.25

All Time High

€1.25